광음향 이미징 시장 보고서 : 제품, 적응증, 용도, 최종 용도, 지역별(2025-2033년)

The global photoacoustic imaging market size reached USD 109 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 317 Million by 2033, exhibiting a growth rate (CAGR) of 12.6% during 2025-2033. The market growth is primarily driven by the ongoing advancements in hybrid imaging technologies, the expanding use of photoacoustic imaging in oncology for high-resolution tumor visualization, and rising investments in research and development to improve diagnostic accuracy and explore new clinical applications.

Photoacoustic imaging, also known as optoacoustic imaging, is a non-invasive biomedical imaging technique that captures images of biological tissues without using ionizing radiation. It is a hybrid modality that functions on the photoacoustic effect, wherein absorbed optical energy is converted into acoustic energy. It offers various advantages over conventional imaging techniques, including high penetration, depth, and image resolution, no harmful ionizing radiation, and molecular targeting at imaging depth. It is employed in detecting physiological properties and naturally occurring chromophores, such as lipids, melanin, hemoglobin concentration, and water and oxygen saturation. Besides this, it is extensively used for tumor mapping, functioning of the brain, detecting skin melanoma, and measuring methemoglobin. As a result, photoacoustic imaging is gaining immense traction across the globe.

Photoacoustic Imaging Market Trends:

Continual Technological Advancements in Imaging Systems

According to the photoacoustic imaging market, the demand is increasing significantly due to ongoing developments in imaging technology. More advanced hybrid imaging systems are offering improved functional imaging and higher resolution through the combination of photoacoustic imaging with optical and ultrasonic approaches. These developments render it possible to visualize biological tissues in real time with better depth penetration and contrast, especially for oncology and cardiovascular applications. Improved image reconstruction and interpretation through advanced software and algorithms are being preferred by the masses. A recent study introduced a non-contact photoacoustic method using a silicon photonics based LDV, which outperformed commercial systems and reconstructed accurate 2D images. These technological innovations are making the systems more versatile, driving their adoption in both research and clinical settings, and supporting the overall market growth.

Growing Application in Oncology

The increasing application of these imaging solutions in oncology is also contributing to the photoacoustic imaging market growth. Its ability to provide high-resolution images of tumor vasculature and tissue oxygenation levels renders the technique invaluable for early cancer detection, tracking treatment response, and guiding surgery. For patients who need repeated scans, non-invasive photoacoustic imaging is a safer option than conventional imaging modalities such as CT and MRI. More precise, real-time diagnostic instruments are becoming increasingly popular as the prevalence of cancer rises worldwide.

Increasing Research and Development Investments

The market is expanding more quickly as a result of the growing research and development (R&D) expenditures, thereby augmenting the photoacoustic imaging market share. In order to improve patient outcomes and diagnostic accuracy, businesses and research institutes are concentrating on developing imaging systems and investigating novel clinical applications. The rapid development of novel contrast agents enhancing the imaging of certain tissues and disorders is another goal of these efforts. In addition to the advancement of core technologies, ongoing innovation in this field is also being further supported by government financing and strategic collaborations between industry and academics. Consequently, research and development endeavors are broadening the possible uses of photoacoustic imaging, propelling demand in diverse medical and research domains, and augmenting photoacoustic imaging market analysis.

Photoacoustic Imaging Market Segmentation:

Breakup by Product:

• Imaging Systems
• Components
  • Lasers
  • Transducers
• Contrast Agents
• Software
• Others

Breakup by Indication:

• Oncology
• Cardiology
• Neurology
• Hematology
• Others

Breakup by Application:

• Pre-Clinical
• Clinical

Breakup by End Use:

• Hospital and Clinics
• Research Institution
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global photoacoustic imaging market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

• Advantest Corporation
• Ekspla (EKSMA group)
• Fujifilm Visualsonics Inc.
• illumiSonics Inc.
• InnoLas Laser GmbH
• iThera Medical GmbH
• kibero GmbH
• Litron Lasers Ltd.
• Opotek LLC
• Photosound Technologies Inc.
• Seno Medical Instruments
• Tomowave Laboratories Inc.

Key Questions Answered in This Report:

• How has the global photoacoustic imaging market performed so far and how will it perform in the coming years ?
• What has been the impact of COVID-19 on the global photoacoustic imaging market ?
• What are the key regional markets ?
• What is the breakup of the market based on the product ?
• What is the breakup of the market based on the indication ?
• What is the breakup of the market based on the application ?
• What is the breakup of the market based on the end use ?
• What are the various stages in the value chain of the industry ?
• What are the key driving factors and challenges in the industry ?
• What is the structure of the global photoacoustic imaging market and who are the key players ?
• What is the degree of competition in the industry ?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Photoacoustic Imaging Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Imaging Systems
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Components
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Lasers
    • 6.2.2.2 Transducers
  • 6.2.3 Market Forecast
• 6.3 Contrast Agents
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Software
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Indication

• 7.1 Oncology
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Cardiology
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Neurology
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Hematology
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Application

• 8.1 Pre-Clinical
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Clinical
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by End Use

• 9.1 Hospital and Clinics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Research Institution
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Advantest Corporation
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Ekspla (EKSMA group)
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Fujifilm Visualsonics Inc.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 illumiSonics Inc.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 InnoLas Laser GmbH
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 iThera Medical GmbH
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 kibero GmbH
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Litron Lasers Ltd.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Opotek LLC
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Photosound Technologies Inc.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Seno Medical Instruments
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 Tomowave Laboratories Inc.
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio